跳至主要内容
临床试验/NCT04944407
NCT04944407已完成不适用

Minimal Invasive Laser Hemorrhoidoplasty vs Conventional Excisional Hemorrhoidectomy in II-III Grade Hemorrhoidal Disease: a Randomized Controlled Trial

University of Campania "Luigi Vanvitelli"2 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
220
试验地点
2
主要终点
Pain evaluation

研究概览

简要总结

the study aims to evaluate the effectiveness and long term outcomes of laser hemorroidoplasty versus conventional milligan morgan hemorrhoidectomy in II-III degree hemorroidal disease.

详细描述

Background Hemorrhoidal disease (HD) is a widespread condition and several surgical techniques have been proposed to date without achieving a definitive consensus. Laser Hemorrhoidoplasty (LHP) is a minimal invasive procedure for HD treatment determining the shrinkage of the hemorrhoidal piles by diode laser limiting the postoperative discomfort and pain. The aim of the current prospective randomized trial is to evaluate the postoperative outcomes of HD patients undergoing LHP vs conventional Milligan-Morgan hemorrhoidectomy (MM).

Methods. Operative time, postoperative pain and complications, resolution of symptoms, patients 'quality of life, patients' evaluation of treatment and length of return to daily activity of II-III grade symptomatic HD patients undergoing LHP vs MM were prospectively evaluated. The patients were followed-up for 24 months looking for recurrence of prolapsed hemorrhoid or symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • II-III hemorrhoidal disease
  • failure of conservative treatment

排除标准

  • acutely thrombosed hemorrhoids
  • patients affected by IBD involving rectum or anus
  • patients previously surgically treated for hemorrhoidal disease and the inability to complete study protocol

结局指标

主要结局

Pain evaluation

时间窗: 30 postoperative days.

postoperative pain assessment with Visual Analogue Scale Score

Analgesic use

时间窗: 30 postoperative days.

use of analgesic drugs in the postopertive days

次要结局

  • Presence of recurrence(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudio Gambardella

Principal Investigator

University of Campania "Luigi Vanvitelli"

研究点 (2)

Loading locations...

相似试验